RebrAIn
Signal active
Organization
Contact Information
Overview
RebrAIn makes it possible for individuals with severe Parkinson's or essential tremor disorder to get DBS treatment with precision targeting. Neurosurgeons can more accurately pinpoint the target location for electrode surgical insertion with the use of this SaaS service. Its innovative method predicts the treatment zone in each patient's brain using machine learning clinical patient data.
About
Industries
Life Science, Hospital, Neuroscience
Founded
2021
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
RebrAIn headquartered in Europe, operates in the Life Science, Hospital, Neuroscience sector. The company focuses on Life Science and has secured $48.3M in funding across 12 round(s). With a team of 1-10 employees, RebrAIn is actively contributing to advancements in Life Science. Their latest funding round, Seed Round - RebrAIn, raised $4.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
2
Lead Investors
0
Total Funding Amount
$4.0M
Details
1
RebrAIn has raised a total of $4.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Seed | 4.0M |
Investors
RebrAIn is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Karista | - | FUNDING ROUND - Karista | 4.0M |
| Jean-Pierre Renaudin | - | FUNDING ROUND - Jean-Pierre Renaudin | 4.0M |
| RebrAIn | - | FUNDING ROUND - RebrAIn | 4.0M |
| NACO | - | FUNDING ROUND - NACO | 4.0M |
Recent Activity
There is no recent news or activity for this profile.